BrightSpring Health Services, Inc. is a home and community-based healthcare services platform that provides complementary pharmacy and provider services to complex patients. The company serves Senior and Specialty populations, including those with behavioral and neurological conditions, primarily in the United States. Its business segments include pharmacy services, offering medication therapy management, infusion, and specialty oncology care, and provider services, encompassing home health, hospice, rehabilitation therapy, and supportive care for activities of daily living. The company also offers home-based primary care for patients in senior living communities and long-term care facilities. BrightSpring serves Medicare, Medicaid, and commercially-insured populations across all 50 states. The company operates through a network of pharmacies, infusion centers, and clinical locations, delivering care to patients in their homes and community settings.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Care Facilities Homepage brightspringhealth.com
Sector Healthcare IR page brightspringhealth.com
Tags
home health, hospice, rehabilitation therapy, specialty pharmacy, medication therapy management, home-based primary care, neurological rehabilitation, behavioral health, senior care, supportive care, All Ways Caring, Adoration
Press page brightspringhealth.com/news

Metrics

Valuation  
Market cap $ 11.283B
Market cap (USD) $ 11.283B
P/E 40.25
PEG —
P/BV 5.18
P/S 0.74
P/OCF 18.72
P/FCF 22.91
Dividend yield —
Turnover / mcap —
Returns  
ROE 10.8%
ROI 4.4%
ROIC 5.1%
Profit margin 1.5%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 100.3%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 45
Quality score -5.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue 12.911B 11.266B 7.691B 7.721B 6.698B
Net profit 190.666M -18.062M -154.603M -53.907M 49.799M
Free cash flow 394.685M -57.139M 137.256M -74.766M 210.895M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Share price 37.45 17.03 — — —
Price performance 12m 1.2 — — — —

Filed figures

Figure Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — 882M 1.03B 990M
↳ YoY growth +16.7% -3.8%
Borrowings, current (USD) — 32.3M 48.7M 52.3M
Borrowings, non-current (USD) — 3.33B 2.56B 2.46B
Lease liabilities (USD) — 306M 294M 200M
Cash and deposits (USD) — 13.1M 61.3M 88.4M
Intangible assets (USD) — 881M 811M 558M
Right-of-use assets (USD) — 267M 250M 172M
Net debt (borrowings + leases - cash) (USD) — 3.66B 2.84B 2.62B
Cash flow detail
Operating cash flow (USD) -4.65M 211M 23.8M 490M
Purchases of property, plant and equipment (USD) -70.1M -73.5M -80.9M -95.5M
Change in receivables (cash effect) (USD) -150M -127M -179M -131M
Change in inventories (cash effect) (USD) -132M 28.7M -237M -178M
Share buybacks (cash effect) (USD) — -650,000 -650,000 -43.2M
Interest paid (cash effect) (USD) -213M -304M -211M -184M
Income taxes paid (cash effect) (USD) -28.9M -37.5M -25M -27M
Share-based compensation (USD) 3.55M 3.92M 69.2M 70.1M
Operating cash flow before change in receivables (USD) 146M 338M 203M 621M
Free cash flow (OCF - PPE - intangibles) (USD) -74.8M 137M -57.1M 395M
Income detail
Total comprehensive income (USD) -26.9M -165M -31.6M 181M
Comprehensive income to owners (USD) -26.6M -163M -29.2M 183M
Provision for credit losses (USD) — 23.3M 34M 56.2M
Credit cost ratio (credit losses / average receivables) (%) — — 3.6% 5.6%
Reported Mar 6, 2025 Mar 6, 2025 Mar 6, 2025 Feb 27, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

LOUISVILLE, Ky., October 30, 2026 — BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home- and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2026, and increased full year 2026 Revenue and Adjusted EBITDA1 guidance.

Third Quarter 2026 Financial Highlights

(note: On March 30, 2026, BrightSpring completed the divestiture of the Community Living business and, as such, all financial results provided pertain to continuing operations)

•Net revenue of $4,213 million, up 26.4% compared to $3,334 million in the third quarter of 2025

•Gross profit of $519 million, up 32.3% compared to $392 million in the third quarter of 2025

•Net income from continuing operations of $101 million compared to $38 million in the third quarter of 2025

•Adjusted EBITDA1 of $228 million, up 42.0% compared to $160 million in the third quarter of 2025

•Leverage of 1.79x as of September 30, 2026, compared to leverage of 2.15x on June 30, 2026

"Our third quarter results again reflect the commitment of our team to patient care and operational execution across our Pharm

October 26, 2026

Onco360® , the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by AstraZeneca Pharmaceuticals for Zegfrovy® (sunvozertinib), which is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.1

“We are honored to be expand our partnership with AstraZeneca and support the launch Zegfrovy by leveraging our quality-driven oncology platform to serve patients with this specific form of non-small cell lung cancer through a coordinated, compassionate approach to treatment access, personalized care and ongoing support,” said Benito Fernandez, Chief Commercial Officer.

Zegfrovy is a kinase inhibitor of the epidermal growth factor receptor (EGFR) that binds to and inhibits EGFR exon 20 insertion mutations at concentrations similar to those for wild-type EGFR.1 Zegfrovy is included in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines® Non-Small Cell Lung Cancer) for NSCLC2. It is recommended as a subsequent therapy option for patients with EGFR exon 20 insertion mutation-positive advanced or metastatic NSCLC.

The WU-KONG28 (NCT05668988) study, a phase 3 international randomized trial, met its primary endpoint, showing that first-line oral Zegfrovy significantly prolonged progression-free survival versus platinum-based chemotherapy in patients with advanced non-squamous NSCLC harboring EGFR exon 20 insertion mutations.3 The median progression-free survival (PFS) was 10.3 months vs 7.5months (HR= 0.65, 95% CI 0.50-085) with chemotherapy. The objective response rate was 58.9% (95% CI 50.9-66.5) with Zegfrovy vs 31.1% (95% CI 24.0-38.8) with chemotherapy. The most common (≥20%) adverse reactions were diarrhea, rash, decreased appetite, stomatitis, fatigue, nausea, paronychia, vomiting, constipation, musculoskeletal pain, pruritus, dry skin, urinary tract infection, abdominal pain, and decreased weight.1

Please read the full prescribing information for Zegfrovy.

About Onco360 Oncology Pharmacy

Onco360 is the nation’s largest independent Oncology Pharmacy and clinical support services company. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. It dispenses nationally through its network of URAC-, and ACHC-accredited Oncology Pharmacies. Onco360 is headquartered in Louisville, Kentucky, and is a flagship specialty pharmacy brand of PharMerica Corporation, a leading institutional pharmacy, specialty infusion, and hospital services company servicing healthcare facilities in the United States. For more information about Onco360, please visit Onco360.com .

# # #

Media Contact:

Benito Fernandez, Chief Commercial Officer

[email protected]

516-640-1332

References:

1ZEGFROVY® (sunvozertinib) [Package Insert]. Shanghai, China. Dizal Pharmaceutical. 2025.

2National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer (Version 9.2026). https://https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf . Accessed 10/9/2026.

3Zhou, C, Greiller, L et al. First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations. N Engl J Med. 2026;395(8):765-775. doi:10.1056/NEJMoa2604461.

 

Next

Our Commitment to Quality

BrightSpring’s clinical and quality team is dedicated to measuring and improving key clinical quality indicators across all lines of business.

Join the BrightSpring Team

At BrightSpring, we invest in our employees by providing opportunities to advance and feel truly fulfilled in the impact of their work. 

WHAT PEOPLE ARE SAYING

We used Adoration to provide home health services to my Mom (age 99) after a partial hip replacement. The physical therapists we worked with were absolutely outstanding… They both treated my mom with kindness – yet really pushed her to achieve success.

Karen s. | Home health (daughter of patient)

What a team! To see the same people every week gave my Gram such comfort… I can’t recommend this service enough. It’s such a difficult time of life for anyone involved, but the staff felt like family to me and my Gram. Thank you everyone!

Ryan T. | Hospice (grandson of patient)

All Ways Caring stepped in to fill the gap. Tiffany has been highly professional but also caring and personal. She found a caregiver who helps my dad with daily needs and who now feels like family. We are grateful!

Carrie M. | Homecare (daughter of patient)

My therapists Daniel and Julie played a huge role in my life. They are patient, kind, loving, they listen, and they truly want to know how I feel and what is happening… Thanks to therapy, the most important thing is that I can live by myself again and don’t have to rely on a caretaker.

Tressa b. | Neurorehabilitation Patient

These people really care about you; the nurses, social workers and Chaplin. Trust me these people will take care of you, going above the limits of what needs you may have. They start the first day they arrive and will get it done no matter what it takes. They check on you 24/7 to make sure your needs are met.

James f. | Hospice (family member)

RWW has to be one of the premier programs for stroke survivors looking to regain their independence and life before stroke…They helped me set realistic expectations, they paid attention to my needs, and encouraged me to push beyond what I previously did in therapy.

Terri w. | Neurorehabilitation patient

BrightSpring Health Services BrightSpring Health Services logo

Search

© 2026 BrightSpring Health Services
805 N. Whittington Parkway,
Louisville, Kentucky 40222

502.394.2100

Manage Consent

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Accept Deny View preferences Save preferences View preferences

Manage consent

October 21, 2026

Throughout October, StepStone Family & Youth Services recognizes National Foster Youth Voice Month by highlighting the importance of listening to young people in foster care, understanding their experiences, and advocating for their needs. StepStone works to ensure youth have opportunities to participate in decisions about their care and that their interests are represented when they are not present or unable to advocate for themselves.

This commitment is especially important for adolescents ages 12 to 18, who face unique challenges during critical developmental years. Consistent support, trusted adult relationships, and a sense of belonging help youth build confidence, develop independence, and prepare for the future.

Foster families play a vital role by providing safe, stable, and nurturing homes where children and teens feel supported and confident to express their needs. StepStone equips caregivers with resources and guidance to help youth navigate challenges, maintain important relationships, and achieve their goals.

StepStone Family & Youth Services provides foster care and family support services in Arizona, Indiana, Georgia, Kentucky, North Carolina, Ohio, Tennessee, Virginia, and West Virginia. Across these communities, StepStone works with youth, foster families, and community partners to promote safety, well-being, and positive long-term outcomes. Through dedicated professionals, supportive foster families, and collaboration with community partners, StepStone works to ensure children and teens have the resources, relationships, and advocacy they need to move forward.

Media Coverage

Arizona

KVOA-Tucson (NBC)

Indiana

21 Alive – Ft. Wayne (ABC)

Georgia

11 Alive – Atlanta (NBC)

Kentucky

Harlan Enterprise

The Advocate-Messenger

The Interior Journal

Middlesboro News

Winchester Sun

Kentucky Today

The Mayfield Messenger

Jessamine Journal

The Paducah Sun

WN.com (World News)

WPSD (NBC)

North Carolina

CBS 17

AOL.com

Tennessee

Clarksville Now

@CYCareworkers (X)

Virginia

Yahoo!news

NRV News

WFXR (FOX)

West Virginia

WDTV 5 (CBS)

WTAP (NBC)

 

Next

Our Commitment to Quality

BrightSpring’s clinical and quality team is dedicated to measuring and improving key clinical quality indicators across all lines of business.

Join the BrightSpring Team

At BrightSpring, we invest in our employees by providing opportunities to advance and feel truly fulfilled in the impact of their work. 

WHAT PEOPLE ARE SAYING

slide 2 of 6

RWW has to be one of the premier programs for stroke survivors looking to regain their independence and life before stroke…They helped me set realistic expectations, they paid attention to my needs, and encouraged me to push beyond what I previously did in therapy.

Terri w. | Neurorehabilitation patient

We used Adoration to provide home health services to my Mom (age 99) after a partial hip replacement. The physical therapists we worked with were absolutely outstanding… They both treated my mom with kindness – yet really pushed her to achieve success.

Karen s. | Home health (daughter of patient)

What a team! To see the same people every week gave my Gram such comfort… I can’t recommend this service enough. It’s such a difficult time of life for anyone involved, but the staff felt like family to me and my Gram. Thank you everyone!

Ryan T. | Hospice (grandson of patient)

All Ways Caring stepped in to fill the gap. Tiffany has been highly professional but also caring and personal. She found a caregiver who helps my dad with daily needs and who now feels like family. We are grateful!

Carrie M. | Homecare (daughter of patient)

My therapists Daniel and Julie played a huge role in my life. They are patient, kind, loving, they listen, and they truly want to know how I feel and what is happening… Thanks to therapy, the most important thing is that I can live by myself again and don’t have to rely on a caretaker.

Tressa b. | Neurorehabilitation Patient

These people really care about you; the nurses, social workers and  Chaplin. Trust me these people will take care of you, going above the limits of what needs you may have. They start the first day they arrive and will get it done no matter what it takes. They check on you 24/7 to make sure your needs are met.

James f. | Hospice (family member)

RWW has to be one of the premier programs for stroke survivors looking to regain their independence and life before stroke…They helped me set realistic expectations, they paid attention to my needs, and encouraged me to push beyond what I previously did in therapy.

Terri w. | Neurorehabilitation patient

We used Adoration to provide home health services to my Mom (age 99) after a partial hip replacement. The physical therapists we worked with were absolutely outstanding… They both treated my mom with kindness – yet really pushed her to achieve success.

Karen s. | Home health (daughter of patient)

BrightSpring Health Services BrightSpring Health Services logo

Search

© 2026 BrightSpring Health Services
805 N. Whittington Parkway,
Louisville, Kentucky 40222

502.394.2100

Manage Consent

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Accept Deny View preferences Save preferences View preferences

Manage consent

Prompts

BrightSpring Health Services, Inc. (ticker BTSG), listed in United States.

ETFs Holding BrightSpring Health Services, Inc.

ETF Weight in ETF Shares Market value As of
SAWS 3.20% 4,190 $ 250.185K Jul 31, 2026
CPAI 1.97% 104,175 $ 7.265M Jun 30, 2026
IVSS 1.64% 6,343 $ 442.361K Jun 30, 2026
FMED 1.45% 12,800 $ 747.52K Aug 31, 2026
JSML 1.33% 80,646 $ 4.815M Jul 31, 2026
FFSM 1.08% 271,571 $ 16.216M Jul 31, 2026
FSCC 1.02% 63,328 $ 3.698M Aug 31, 2026
AFMC 0.80% 29,690 $ 2.119M Nov 16, 2026
TMSL 0.80% 308,313 $ 21.502M Jun 30, 2026
FSEG 0.74% 604 $ 42.123K Jun 30, 2026
SEIS 0.72% 59,705 $ 4.164M Jun 30, 2026
JSMD 0.69% 122,189 $ 7.296M Jul 31, 2026
AFSM 0.69% 14,039 $ 1.002M Nov 16, 2026
FLDZ 0.58% 340 $ 23.712K Jun 30, 2026
LITL 0.57% 462 $ 32.261K Nov 17, 2026
CVRT 0.52% 1,602 $ 319.567K Jul 31, 2026
PSC 0.52% 173,428 $ 12.095M Jun 30, 2026
OASC 0.52% 8,321 $ 485.946K Aug 31, 2026
MEDI 0.50% 3,128 $ 223.496K Nov 12, 2026
RESM 0.49% 258 $ 17.993K Jun 30, 2026
FESM 0.44% 367,411 $ 25.623M Jun 30, 2026
MSSM 0.43% 52,541 $ 3.068M Aug 31, 2026
MMSC 0.42% 2,973 $ 212.183K Nov 16, 2026
GVLU 0.31% 11,416 $ 814.76K Nov 17, 2026
VFMO 0.23% 76,228 $ 4.452M Aug 31, 2026
RUSC 0.23% 2,627 $ 183.207K Jun 30, 2026
SHRT 0.22% 394 $ 28.12K Nov 17, 2026
IALT short -0.19% -207,329 $ -14.797M Nov 16, 2026
DFAS 0.19% 869,578 $ 62.131M Nov 12, 2026
VFQY 0.13% 10,960 $ 640.064K Aug 31, 2026
FTLS 0.11% 39,548 $ 0.00 Nov 16, 2026
VFMF 0.06% 10,186 $ 594.862K Aug 31, 2026
DFAC 0.05% 672,879 $ 48.077M Nov 12, 2026
DFUV 0.04% 93,089 $ 6.651M Nov 12, 2026
DXUV 0.03% 30,586 $ 2.185M Nov 12, 2026
DFSU 0.03% 9,252 $ 661.055K Nov 12, 2026
DFAU 0.02% 41,409 $ 2.959M Nov 12, 2026
DFUS 0.02% 48,709 $ 3.48M Nov 12, 2026
DCOR 0.01% 61,742 $ 4.411M Nov 12, 2026
EBI 0.01% 1,127 $ 65.817K Aug 31, 2026
AVSU 0.00% 25 $ 1,784.25 Nov 16, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
BTSG canonical Common share — US nasdaq 56.75 USD 2026-09-30
BTSGU Unit — US nasdaq — —